首页> 外文期刊>中华医学杂志(英文版) >Association between Serum 25-hydroxy Vitamin D Concentration and TaqI Vitamin D Receptor Gene Polymorphism among Jordanian Females with Breast Cancer
【24h】

Association between Serum 25-hydroxy Vitamin D Concentration and TaqI Vitamin D Receptor Gene Polymorphism among Jordanian Females with Breast Cancer

机译:约旦乳腺癌女性血清25-羟基维生素D浓度与TaqI维生素D受体基因多态性的关系

获取原文
获取原文并翻译 | 示例
           

摘要

Background:Breast cancer is the most common type of cancer among females.Genetic polymorphisms might have a role in carcinogenesis.The aim of this study was to determine whether C to T base substitution within TaqI Vitamin D receptor (VDR) gene (rs731236) in exon 9 was a risk factor among patients with breast cancer.Methods:Peripheral blood was drawn from 122 Jordanian breast cancer patients and 100 healthy Jordanian volunteers in Al-Basheer Hospital during the summer months (from June to November of 2013,2014,and 2015).DNA was amplified using polymerase chain reaction (PCR),followed by TaqI restriction enzyme digestion.Quantification of serum 25-hydroxy Vitamin D (25[OH]D) level was determined by competitive immunoassay Elecsys.Results:Genotypic frequencies for TaqI TT,Tt,and tt genotypes were 41%,46%,and 13% for breast cancer compared to 42%,50%,and 8% for control,respectively.Vitamin D serum level was significantly lower in the breast cancer patients (8.1 ± 0.3 ng/ml) compared to the control group (21.2 ± 0.6 ng/ml;P =0.001).This study showed an inverse association between 25(OH)D serum level and breast cancer risk (odds ratio [OR],22.72,95% confidence interval [CI],10.06-51.29).Conclusions:An inverse association was found between 25(OH)D serum level and breast cancer risk.Statistical difference was also found between different VDR TaqIgenotypes and circulating levels of 25(OH)D among Jordanian females with breast cancer.
机译:背景:乳腺癌是女性中最常见的癌症类型。基因多态性可能与致癌作用有关。本研究的目的是确定TaqI维生素D受体(VDR)基因(rs731236)中的C到T碱基取代。第9外显子是乳腺癌患者的危险因素。方法:在夏季(2013年6月至11月,2014年11月至2015年11月)在Al-Basheer医院抽取122名约旦乳腺癌患者和100名健康约旦志愿者的外周血。 )。通过聚合酶链反应(PCR)扩增DNA,然后进行TaqI限制性内切酶消化。竞争性免疫分析Elecsys对血清25-羟基维生素D(25 [OH] D)水平进行定量。结果:TaqI TT的基因型频率,Tt和tt基因型分别为乳腺癌的41%,46%和13%,而对照的分别为42%,50%和8%。乳腺癌患者中的维生素D血清水平显着降低(8.1± 0.3 ng / ml)与对照组(21.2±0.6 ng / ml; P = 0.001)。这项研究显示25(OH)D血清水平与乳腺癌风险呈负相关(比值[OR],22.72,95%置信区间[CI]) ,10.06-51.29)。结论:约旦女性乳腺癌患者中25(OH)D血清水平与乳腺癌风险呈负相关。不同VDR Taq基因型与25(OH)D循环水平之间也存在统计学差异。 。

著录项

  • 来源
    《中华医学杂志(英文版)》 |2017年第9期|1074-1078|共5页
  • 作者单位

    Department of Medical Laboratory Sciences, Faculty of Allied Health, Hashemite University, Zarqa 13115, Jordan;

    Department of Medical Laboratory Sciences, Faculty of Allied Health, Hashemite University, Zarqa 13115, Jordan;

  • 收录信息 中国科学引文数据库(CSCD);中国科技论文与引文数据库(CSTPCD);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号